Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,732 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $291.28 | 10 | $0 (2021) |
| AbbVie, Inc. | $218.95 | 2 | $0 (2019) |
| Edwards Lifesciences Corporation | $197.74 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $195.94 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $146.79 | 5 | $0 (2024) |
| Horizon Therapeutics plc | $125.00 | 1 | $0 (2022) |
| Veloxis Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.49 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $105.60 | 5 | $0 (2019) |
| PBG PUERTO RICO LLC | $103.12 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.66 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($100.49) |
| 2023 | $55.23 | 2 | GlaxoSmithKline, LLC. ($30.35) |
| 2022 | $238.57 | 4 | Horizon Therapeutics plc ($125.00) |
| 2021 | $25.00 | 1 | E.R. Squibb & Sons, L.L.C. ($25.00) |
| 2020 | $23.81 | 1 | AstraZeneca Pharmaceuticals LP ($23.81) |
| 2019 | $619.76 | 11 | AbbVie, Inc. ($218.95) |
| 2018 | $495.75 | 13 | Edwards Lifesciences Corporation ($197.74) |
| 2017 | $117.15 | 5 | Merck Sharp & Dohme Corporation ($60.07) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | PBG PUERTO RICO LLC | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $100.49 | General |
| Category: DIABETES | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2023 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $30.35 | General |
| 12/06/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: KRYSTEXXA | ||||||
| 10/20/2022 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiovascular | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Cardiovascular | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Virology | ||||||
| 08/01/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: Cardiovascular | ||||||
| 05/30/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $103.95 | General |
| Category: Virology | ||||||
| 05/16/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/09/2019 | PBG PUERTO RICO LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/30/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: Cardiovascular | ||||||
| 04/25/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunosuppressant | ||||||
| 02/07/2019 | PFIZER PHARMACEUTICALS LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2018 | PFIZER PHARMACEUTICALS LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.96 | General |
| Category: Cardiovascular | ||||||
| 09/11/2018 | Edwards Lifesciences Corporation | ClearSight System (Device) | Food and Beverage | In-kind items and services | $84.30 | General |
| Category: Noninvasive Hemodynamic Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 292 | 682 | $81,270 | $44,853 |
| 2022 | 6 | 332 | 916 | $103,730 | $55,758 |
| 2021 | 6 | 312 | 895 | $102,970 | $58,401 |
| 2020 | 5 | 407 | 1,246 | $143,780 | $84,025 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 459 | $47,700 | $28,422 | 59.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 46 | $10,580 | $6,277 | 59.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 67 | 75 | $11,250 | $4,707 | 41.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 61 | 61 | $7,320 | $3,519 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 27 | $3,720 | $1,857 | 49.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 14 | $700.00 | $70.45 | 10.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 101 | 658 | $65,800 | $37,146 | 56.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 58 | $13,340 | $9,094 | 68.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 66 | 78 | $11,700 | $4,419 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 52 | 52 | $6,240 | $3,414 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $4,200 | $1,370 | 32.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 49 | 49 | $2,450 | $316.22 | 12.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 104 | 663 | $66,300 | $38,183 | 57.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 64 | 78 | $17,940 | $12,517 | 69.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 63 | 72 | $10,800 | $4,169 | 38.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 49 | 49 | $5,880 | $3,247 | 55.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 15 | 16 | $1,200 | $169.92 | 14.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 17 | 17 | $850.00 | $114.07 | 13.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 158 | 965 | $96,500 | $56,435 | 58.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 97 | 115 | $25,340 | $18,610 | 73.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 93 | 107 | $16,050 | $6,279 | 39.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 42 | 42 | $5,040 | $2,584 | 51.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 17 | 17 | $850.00 | $116.72 | 13.7% |
About Dr. Enrique Ramos, M.D
Dr. Enrique Ramos, M.D is a Family Medicine healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386621043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Enrique Ramos, M.D has received a total of $1,732 in payments from pharmaceutical and medical device companies, with $156.66 received in 2024. These payments were reported across 40 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,732).
As a Medicare-enrolled provider, Ramos has provided services to 1,343 Medicare beneficiaries, totaling 3,739 services with total Medicare billing of $243,037. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Juan, PR
- Active Since 12/23/2005
- Last Updated 04/30/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386621043
Products in Payments
- ELIQUIS (Drug) $434.35
- Mavyret (Drug) $218.95
- ClearSight System (Device) $197.74
- LOKELMA (Drug) $164.81
- XARELTO (Drug) $146.79
- Envarsus (Drug) $125.00
- KRYSTEXXA (Biological) $125.00
- JARDIANCE (Drug) $120.49
- JANUVIA (Drug) $74.60
- Livalo (Drug) $31.72
- BEVESPI AEROSPHERE (Drug) $31.13
- INVANZ (Drug) $17.00
- ZOSTAVAX (Biological) $14.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in San Juan
Mrs. Lizette Santiago, M.d, M.D
Family Medicine — Payments: $488,982
Beigno Gonzalez
Family Medicine — Payments: $55,114
Dr. Carlos Sariol, Md, MD
Family Medicine — Payments: $28,941
Dr. Victor Villarreal, Md, MD
Family Medicine — Payments: $16,256
Jose Mulero Fernandez, Md, MD
Family Medicine — Payments: $10,188
Dr. Carlos Vera Muniz, Md, MD
Family Medicine — Payments: $9,414